BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2682204)

  • 1. Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland.
    Jarvie KR; Booth G; Brown EM; Niznik HB
    Mol Pharmacol; 1989 Oct; 36(4):566-74. PubMed ID: 2682204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.
    Jarvie KR; Niznik HB; Seeman P
    Mol Pharmacol; 1988 Aug; 34(2):91-7. PubMed ID: 2970586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D1 receptors of the calf parathyroid gland: identification of a ligand binding subunit with lower apparent molecular weight but similar primary structure to neuronal D1-receptors.
    Niznik HB; Jarvie KR; Brown EM
    Biochemistry; 1989 Aug; 28(17):6925-30. PubMed ID: 2531003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deglycosylation and proteolysis of photolabeled D2 dopamine receptors of the porcine anterior pituitary.
    Jarvie KR; Niznik HB
    J Biochem; 1989 Jul; 106(1):17-22. PubMed ID: 2528540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoaffinity labeling of dopamine D1 receptors.
    Niznik HB; Jarvie KR; Bzowej NH; Seeman P; Garlick RK; Miller JJ; Baindur N; Neumeyer JL
    Biochemistry; 1988 Oct; 27(20):7594-9. PubMed ID: 3207691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct demonstration of D1 dopamine receptors in the bovine parathyroid gland using the D1 selective antagonist [125I]-SCH 23982.
    Monsma FJ; Sibley DR
    Synapse; 1989; 3(3):193-9. PubMed ID: 2524116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 receptors of the calf parathyroid gland: identification and characterization.
    Niznik HB; Fogel EL; Chen CJ; Congo D; Brown EM; Seeman P
    Mol Pharmacol; 1988 Jul; 34(1):29-36. PubMed ID: 2839763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation of the mammalian alpha 1-adrenergic receptor by complex type N-linked oligosaccharides.
    Sawutz DG; Lanier SM; Warren CD; Graham RM
    Mol Pharmacol; 1987 Nov; 32(5):565-71. PubMed ID: 2824978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional difference in brain benzodiazepine receptor carbohydrates.
    Sweetnam PM; Tallman JF
    Mol Pharmacol; 1986 Mar; 29(3):299-306. PubMed ID: 3005837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking.
    Amlaiky N; Berger JG; Chang W; McQuade RJ; Caron MG
    Mol Pharmacol; 1987 Feb; 31(2):129-34. PubMed ID: 3807891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian beta-adrenergic receptors. Distinct glycoprotein populations containing high mannose or complex type carbohydrate chains.
    Stiles GL; Benovic JL; Caron MG; Lefkowitz RJ
    J Biol Chem; 1984 Jul; 259(13):8655-63. PubMed ID: 6330118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation characteristics of the mouse liver lactogenic receptor.
    Lascols O; Capeau J; Cherqui G; Caron M; Bachimont J; Picard J
    Mol Cell Endocrinol; 1989 Aug; 65(1-2):145-55. PubMed ID: 2506088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between mouse lymphocyte receptors for peanut agglutinin (PNA) and Helix pomatia agglutinin (HPA).
    De Petris S; Takacs B
    Eur J Immunol; 1983 Oct; 13(10):831-40. PubMed ID: 6357809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-linked oligosaccharides are responsible for rat striatal dopamine D2 receptor heterogeneity.
    Clagett-Dame M; McKelvy JF
    Arch Biochem Biophys; 1989 Oct; 274(1):145-54. PubMed ID: 2528326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel affinity purification of D-1 dopamine receptors from rat striatum.
    Sidhu A
    J Biol Chem; 1990 Jun; 265(17):10065-72. PubMed ID: 2141020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation.
    Grigoriadis DE; De Souza EB
    Endocrinology; 1989 Oct; 125(4):1877-88. PubMed ID: 2551631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter: deglycosylation with exo- and endoglycosidases.
    Lew R; Grigoriadis D; Wilson A; Boja JW; Simantov R; Kuhar MJ
    Brain Res; 1991 Jan; 539(2):239-46. PubMed ID: 2054600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein nature of the A2-adenosine receptor binding subunit.
    Barrington WW; Jacobson KA; Stiles GL
    Mol Pharmacol; 1990 Aug; 38(2):177-83. PubMed ID: 2385230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a high affinity and stereoselective photoaffinity label for the D-1 dopamine receptor: synthesis and resolution of 7-[125I]iodo-8-hydroxy-3-methyl-1-(4'-azidophenyl)-2,3,4,5-tetrahydro- 1H-3-benzazepine.
    Neumeyer JL; Baindur N; Yuan J; Booth G; Seeman P; Niznik HB
    J Med Chem; 1990 Feb; 33(2):521-6. PubMed ID: 2405157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein nature of D2 dopamine receptors.
    Grigoriadis DE; Niznik HB; Jarvie KR; Seeman P
    FEBS Lett; 1988 Jan; 227(2):220-4. PubMed ID: 2962888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.